A new reassortment of influenza A (H7N9) virus causing human infection in Beijing, 2014

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Bi, Yuhai ^a,b,c   Liu, Jingyuan ^d   Xiong, Haofeng ^d   Zhang, Yue ^d,e   Liu, Di ^b,c   Liu, Yingxia ^a   Gao, George F ^a,b,c   Wang, Beibei ^d,e  

^a SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e Beijing Key Laboratory of Emerging Infectious Diseases   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

AGED; ANIMAL; CASE REPORT; CHINA; DOG; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H7N9); ISOLATION AND PURIFICATION; MALE; MDCK CELL LINE;

AGED; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHINA; DOGS; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; MALE;

EID: 84971320503     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26624     Document Type: Article

References (40)

1. Gao, H. N. et al. Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection. New England Journal of Medicine 368, 2277-2285 (2013).
2. Fang, L. Q. et al. Mapping spread and risk of avian influenza A (H7N9) in China. Sci Rep 3, 2722 (2013).
3. Cui, L. B. et al. Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus. Nature Communications 5, 3142 (2014).
4. Lu, J. et al. Genetic Changes of Reemerged Influenza A(H7N9) Viruses, China. Emerging Infectious Disease 20, 1582-1583 (2014).
5. Wu, A. P. et al. Sequential Reassortments Underlie Diverse Influenza H7N9 Genotypes in China. Cell Host & Microbe 14, 446-452 (2013).
6. Lam, T. T. Y. et al. Dissemination, divergence and establishment of H7N9 influenza viruses in China. Nature 522, 102-105 (2015).
7. Dennis, K. M. et al. Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series. BMJ 346, f3693 (2013).
8. Chen, E. et al. Human infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013. Euro Surveill 18, 20616, doi: 10.2807/1560-7917.ES2013.18.43.20616 (2013).
9. Song, R. et al. Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection 42, 127-133 (2014).
10. Gao, R. et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368, 1888-1897 (2013).
11. de Jong, M. D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12, 1203-1207 (2006).
12. Zhou, J. et al. Biological features of novel avian influenza A (H7N9) virus. Nature 499, 500-503 (2013).
13. Price, G. E., Gaszewska-Mastarlarz, A. & Moskophidis, D. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J Virol 74, 3996-4003 (2000).
14. Zhang, A. et al. Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013. Eurosurveillance 18, 38-45 (2013).
15. Tisoncik, J. R. et al. Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76, 16-32 (2012).
16. Mok, C. K. et al. Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J Virol 88, 3568-3576 (2014).
17. Meliopoulos, V. A. et al. Human H7N9 and H5N1 influenza viruses differ in induction of cytokines and tissue tropism. J Virol 88, 12982-12991 (2014).
18. Conenello, G. M., Zamarin, D., Perrone, L. A., Tumpey, T. & Palese, P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3, 1414-1421 (2007).
19. Seo, S. H. & Webster, R. G. Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J Virol 76, 1071-1076 (2002).
20. Woods, C. J., Malaisree, M., Long, B., McIntosh-Smith, S. & Mulholland, A. J. Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity. Sci Rep 3, 3561 (2013).
21. Hui, D. S. & Hayden, F. G. Editorial commentary: Host and viral factors in emergent influenza virus infections. Clin Infect Dis 58, 1104-1106 (2014).
22. Wang, Z. et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci USA 111, 769-774 (2014).
23. Yang, Z. F. et al. Clinical, virological and immunological features from patients infected with re-emergent avian-origin human H7N9 influenza disease of varying severity in Guangdong province. PLoS One 10, e0117846 (2015).
24. Guo, J. et al. The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes. Sci Rep 5, 10942 (2015).
25. Zeng, H. et al. A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus. J Virol 89, 4655-4667 (2015).
26. Tharakaraman, K. et al. A broadly neutralizing human monoclonal antibody is effective against H7N9. Proc Natl Acad Sci USA 112, 10890-10895 (2015).
27. Perrone, L. A., Plowden, J. K., Garcia-Sastre, A., Katz, J. M. & Tumpey, T. M. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4, e1000115 (2008).
28. Bi, Y. et al. Assessment of the Internal Genes of Influenza A (H7N9) Virus Contributing to High Pathogenicity in Mice. J Virol 89, 2-13 (2015).
29. Jin, S., Li, Y., Pan, R. & Zou, X. Characterizing and controlling the inflammatory network during influenza A virus infection. Sci Rep 4, 3799 (2014).
30. Frazier, W. J. & Hall, M. W. Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am 55, 647-668, xi (2008).
31. Norrby-Teglund, A., Pauksens, K., Norgren, M. & Holm, S. E. Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. Scand J Infect Dis 27, 125-130 (1995).
32. Wang, H. & Ma, S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 26, 711-715 (2008).
33. Chen, Y. et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381, 1916-1925 (2013).
34. Chi, Y. et al. Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. J Infect Dis 208, 1962-1967 (2013).
35. Qian, W. et al. Kinetic analysis of the immunity in a pregnant patient infected with avian influenza H7N9. Int J Clin Exp Med 7, 1768-1774 (2014).
36. Wu, W. et al. Immune derangement occurs in patients with H7N9 avian influenza. Crit Care 18, R43 (2014).
37. Yang, S. et al. Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study. J Infect Dis 209, 265-269 (2014).
38. Hoffmann, E., Stech, J., Guan, Y., Webster, R. G. & Perez, D. R. Universal primer set for the full-length amplification of all influenza A viruses. Archives of Virology 146, 2275-2289 (2001).
39. Li, O. T. W. et al. Reliable universal RT-PCR assays for studying influenza polymerase subunit gene sequences from all 16 haemagglutinin subtypes. Journal of Virological Methods 142, 218-222 (2007).
40. Yu, Q. et al. Risk Perceptions for Avian Influenza Virus Infection among Poultry Workers, China. Emerging Infectious Diseases 19, 313-316 (2013).